Zobrazeno 1 - 10
of 474
pro vyhledávání: '"Deb tace"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background A majority of esophageal carcinoma patients are diagnosed at an advanced stage and are no longer suitable for surgical resection. Drug-eluting beads transarterial chemoembolization (DEB-TACE) with oxaliplatin-loaded CalliSpheres b
Externí odkaz:
https://doaj.org/article/0d5652cdfd27419dbae2e663234f0528
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The liver is the fourth most common site of metastasis in renal cell carcinoma (RCC), which is usually treated with systemic therapies and local treatments. However, local treatments are challenging in RCC patients with liver metastasis who failed in
Externí odkaz:
https://doaj.org/article/84bd336b889f4e14a7d86260be617b5e
Autor:
Youssef Zaarour, Haytham Derbel, Charles Tran, Laetitia Saccentia, Benjamin Longère, Maxime Blain, Giuliana Amaddeo, Alain Luciani, Hicham Kobeiter, Vania Tacher
Publikováno v:
Research in Diagnostic and Interventional Imaging, Vol 10, Iss , Pp 100048- (2024)
Rationale and objectives: A new microcatheter was recently developed claiming to reduce beads reflux in drug-eluting bead transarterial chemoembolization (DEB-TACE). The aim of this study was to compare the reflux control microcatheter ability versus
Externí odkaz:
https://doaj.org/article/1e49901503304616a95a632fc7805a64
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Our objective was to assess the efficacy and safety of initial hepatic arterial infusion of chemotherapy combined with transarterial chemoembolisation using camrelizumab-eluting Callisphere beads (camrelizumab-DEB-TACE) for treati
Externí odkaz:
https://doaj.org/article/498f0887371c4bec9e5c58cbeb8d7bc6
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Objective CalliSpheres® is a microsphere that is already widely used for primary liver cancer treatment; however, its application in colorectal cancer liver metastasis (CRLM) is limited. The current study aimed to investigate the efficacy o
Externí odkaz:
https://doaj.org/article/c4026e09231f4c29be5004f66e799d27
Publikováno v:
Radiology and Oncology, Vol 57, Iss 1, Pp 70-79 (2023)
This trial aimed to compare the outcomes of drug-eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres® microspheres (CSM) and conventional transarterial chemoembolization cTACE in the treatment of patients with unresectable hep
Externí odkaz:
https://doaj.org/article/a1b796c602134377aeea77fd78a56475
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background Drug-eluting bead transarterial chemoembolization (DEB-TACE) with Callispheres® beads (CB) is currently used in the treatment of hepatocellular carcinoma. However, clinical data regarding DEB-TACE using raltitrexed-eluting CB for
Externí odkaz:
https://doaj.org/article/2114a3bc79794047a62e252171464919
Publikováno v:
Journal of Interventional Medicine, Vol 5, Iss 1, Pp 10-14 (2022)
Objective: To compare the safety of conventional transarterial chemoembolization (cTACE) vs drug-eluting bead TACE (DEB-TACE) in very early- and early-stage hepatocellular carcinoma (HCC). Methods: Data of patients with early- and very early-stage HC
Externí odkaz:
https://doaj.org/article/d2b4fb68b2d64c2485f239f1f9de1f88
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 8, Pp 1459-1471 (2021)
Tao Ouyang,1,* Junxia Liu,2,* Chengyang Shi,3 Lisheng Zhu,4 Xiaopeng Guo1 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Cancer Medical Ce
Externí odkaz:
https://doaj.org/article/d35244ef9c7b42a7857fe47e9cd700b8